HEALTH ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026 Saturday, May 16, 2026 · impact biotech Advertisement Read Original Article → Related Dispatches [EU] · May 21 Emerging Sub-Segments Transforming the Clinical Trials Market Landscape [US] · May 21 Dear Doctor: Neurosurgeon botched back surgery, pain is worse by the day; is there any hope? [EU] · May 21 KKR Invests in Fresha, the Leading AI-Powered Platform for Beauty and Wellness, at $1bn Valuation